Summary – Bayer’s blockbuster hopes for Nubeqa just got a little brighter, thanks to a phase 3 trial win that could result…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
Trial
-
-
Agrochemicals
New Proton Pump Inhibitors – Crystalline Patent Abeprazan Succinate (DWP14012) – Granted to Korean Firm Daewoong
by adminby adminAbeprazan (DWP14012) is a potassium-competitive acid blocker. Abeprazan inhibits H+, K+– ATPase by reversible potassium-competitive ionic binding with no acid activation required. Abeprazan is…
-
Agrochemicals
Pfizer to allow Generic Versions of its Covid-19 Pill (Paxlovid) in 95 Countries
by adminby adminKEYPOINTS: Pfizer Inc allow generic manufacturers to supply its experimental antiviral Covid-19 pill to 95 low- and middle-income countries. This will be…
-
Gsk
GlaxoSmithKline’s Novel Anemia (Daprodustat) has Notched up A First-In-Class Success While AstraZeneca-FibroGen’s Akebia Failed.
by adminby adminSYNOPSIS: GlaxoSmithKline Plc released positive trial results for a potential blockbuster anemia pill the company is hoping will bolster its pharma portfolio…
-
Pharma Science & Research
ICEBERG Study Demonstrates Improved Outcomes Of Esketamine Nasal Spray For Treatment-Resistant Depression
by adminby adminSUMMARY: Janssen’s ICEBERG study has demonstrated that Esketamine nasal spray (NS) has shown improved outcomes in an indirect treatment comparison with other…
-
Active Pharmaceutical Ingredients (API)ATG-101Pharma Science & Research
Antengene Receives FDA Approval of IND for Phase 1 Trial of ATG-101 (PD-L1/4-1BB bispecific antibody) in Solid Tumors and Non-Hodgkin Lymphoma.
by adminby adminKEYPOINTS; Antengene Corporation Limited announced that the US Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for…
-
CompaniesNovartis
Novartis’s BLA has been accepted by US FDA & EMA for Kymriah (Tisagenlecleucel) to treat patients with relapsed or refractory follicular lymphoma.
by adminby adminNovartis says that the U.S. and European regulators have accepted its marketing applications for CAR-T cell therapy Kymriah (Tisagenlecleucel) as third-line therapy…
-
ChinaPharma Science & Research
Green Signal for Kintor Pharma, PD-L1/TGF-β dual-targeting antibody (GT90008) for Tumour Clinical Trail from China NMPA
by adminby adminKintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the clinical trial of…
-
Global MarketPharma Science & Research
Himalayan caterpillar fungus possessing Anti- Cancer Activity Shows Potential and Promising Results in Phase 1 Clinical Trial
by adminby adminSynopsis– The chemotherapy has been developed from a molecule found in Himalayan caterpillar fungus and is still in the experimental testing stages. The…
Older Posts